BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2983069)

  • 1. Characterization of cholecystokinin receptor sites in guinea-pig cortical membranes using [125I]Bolton Hunter-cholecystokinin octapeptide.
    Lin CW; Miller T
    J Pharmacol Exp Ther; 1985 Mar; 232(3):775-80. PubMed ID: 2983069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity.
    Knapp RJ; Vaughn LK; Fang SN; Bogert CL; Yamamura MS; Hruby VJ; Yamamura HI
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1278-86. PubMed ID: 2262906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe.
    Wennogle LP; Steel DJ; Petrack B
    Life Sci; 1985 Apr; 36(15):1485-92. PubMed ID: 2984502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-A cholecystokinin receptors in CHP212 neuroblastoma cells: evidence for association with G protein and activation of phosphoinositide hydrolysis.
    Barrett RW; Steffey ME; Wolfram CA
    Mol Pharmacol; 1989 Apr; 35(4):394-400. PubMed ID: 2539554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative autoradiographic localization of cholecystokinin receptors in rat and guinea pig brain using 125I-Bolton-Hunter-CCK8.
    Niehoff DL
    Peptides; 1989; 10(2):265-74. PubMed ID: 2755869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous measurement of cholecystokinin-stimulated amylase release and cholecystokinin receptor binding in rat pancreatic acini.
    Blevins GT; Doi R; Tangoku A; Chowdhury P; McKay D; Rayford PL
    J Lab Clin Med; 1992 May; 119(5):566-73. PubMed ID: 1374786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand.
    Van Dijk A; Richards JG; Trzeciak A; Gillessen D; Möhler H
    J Neurosci; 1984 Apr; 4(4):1021-33. PubMed ID: 6325601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
    Hogaboom GK; Mong S; Stadel JM; Crooke ST
    Mol Pharmacol; 1985 Feb; 27(2):236-45. PubMed ID: 2982090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid down-regulation of substance P binding to guinea-pig pancreatic acinar cells during homologous desensitization.
    Sjödin L; Viitanen E; Gylfe E
    J Physiol; 1994 Apr; 476(1):69-77. PubMed ID: 7519262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]PD 140376: a novel and highly selective antagonist radioligand for the cholecystokininB/gastrin receptor in guinea pig cerebral cortex and gastric mucosa.
    Hunter JC; Suman-Chauhan N; Meecham KG; Dissanayake VU; Hill DR; Pritchard MC; Kneen CO; Horwell DC; Hughes J; Woodruff GN
    Mol Pharmacol; 1993 Apr; 43(4):595-602. PubMed ID: 8474432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of receptors for cholecystokinin and related peptides in mouse cerebral cortex.
    Saito A; Goldfine ID; Williams JA
    J Neurochem; 1981 Aug; 37(2):483-90. PubMed ID: 6267205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin13 and the C-terminal octapeptide of cholecystokinin are differently coupled to G-proteins in guinea-pig brain membranes.
    Lallement JC; Galleyrand JC; Lima-Leite AC; Fulcrand P; Martinez J
    Eur J Pharmacol; 1994 May; 267(3):297-305. PubMed ID: 8088368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
    Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.